BioSpace News Archive

FDA

Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) today announced that the U.S. Food and Drug Administration (FDA) has approved OMLONTI® (omidenepag isopropyl ophthalmic solution) 0.002% eye drops for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.

September 26, 2022
·
7 min read
Pharm Country

SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced receipt of approximately $16 million of international procurement orders for oral TPOXX®.

September 26, 2022
·
9 min read
The University of Barcelona and Poietis announce their partnership to set-up a GMP-compliant bioprinting facility in the Production and Validation Center for Advanced Therapies of the University (CREATIO)

With the acquisition of the NGB (Next-Generation Bioprinting) high-resolution robotic bioprinting platform developed by Poietis the University of Barcelona becomes a reference in Tissue Engineering

September 26, 2022
·
5 min read
Business

Icon Group and Varian Collaborate on an International HyperArc Registry to Advance Treatment of Brain Tumors

This World Cancer Research Day, Icon Group (Icon) becomes the first international participant in the HyperArc® registry, which is sponsored by Varian, a Siemens Healthineers company (Varian).

September 26, 2022
·
4 min read
Increase in Liposarcoma Cases Across the Globe is Expected to Drive Liposarcoma Treatment Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Liposarcoma Treatment Market – Forecast to 2030,’ thoroughly examines the Liposarcoma Treatment industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
Increase in Incidence Rate of Pheochromocytoma is Expected to Drive Pheochromocytoma Market Growth by 2030 - Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Pheochromocytoma Market – Forecast to 2030,’ thoroughly examines the Pheochromocytoma industry to provide essential data & information for the targeted readers.

September 26, 2022
·
6 min read
PharmAbcine to Participate in BIO-Europe 2022

PharmAbcine Inc. announced today that the Company will participate in the upcoming BIO-Europe 2022 which will take place in Leipzig, Germany on October 24 – 26, 2022.

September 26, 2022
·
3 min read
Pharm Country

Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2

Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEWs™ line, a breakthrough RNA gene expression platform powered by Enzo’s LoopRNA™ in situ hybridization technology.

September 26, 2022
·
4 min read
BioCapital

Infectious Diseases Society of America Foundation Announces Applications for Microbial Pathogenesis in Alzheimer’s Research Grant

The Infectious Diseases Society of America Foundation is now accepting applications for the Microbial Pathogenesis in Alzheimer’s Disease Grant.

September 26, 2022
·
2 min read
FDA

Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia

Pulse Biosciences, Inc. today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its CellFX System.

September 26, 2022
·
4 min read